Annual report pursuant to Section 13 and 15(d)

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail)

v3.8.0.1
Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]      
Equity in earnings $ 35,985 $ 31,962 $ 28,126
Equity in other comprehensive loss (248) (89) 3,119
NCM      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance 189,995    
Beginning Balance (343,928)    
Ending Balance 200,550 189,995  
Ending Balance (351,706) (343,928)  
Investment In NCM      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance 189,995 183,755 178,939
Receipt of common units due to annual common unit adjustment 18,363 11,111 15,421
Receipt of excess cash distributions (15,093) (11,233) (14,072)
Receipt under tax receivable agreement (2,265) (2,985) (2,308)
Equity in earnings 9,550 9,347 8,510
Equity in other comprehensive loss     (2,735)
Ending Balance 200,550 189,995 183,755
Deferred Revenue      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance (343,928) (342,134) (335,219)
Receipt of common units due to annual common unit adjustment (18,363) (11,111) (15,421)
Ending Balance (351,706) (343,928) (342,134)
Deferred Revenue | NCM      
Schedule Of Equity Method Investments [Line Items]      
Amortization of deferred revenue 10,585 9,317 8,506
Distributions from NCM      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance (14,656) (18,140)  
Receipt of excess cash distributions (14,158) (11,483) (15,396)
Receipt under tax receivable agreement (2,249) (3,173) (2,744)
Ending Balance (16,407) (14,656) (18,140)
Equity in Earnings      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance (9,347) (8,510)  
Ending Balance (9,550) (9,347) (8,510)
Equity in Earnings | NCM      
Schedule Of Equity Method Investments [Line Items]      
Equity in earnings (9,550) (9,347) (8,510)
Other Revenue      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance (20,365) (19,836)  
Revenues earned under ESA [1] (11,274) (11,048) (11,330)
Ending Balance (21,859) (20,365) (19,836)
Other Revenue | NCM      
Schedule Of Equity Method Investments [Line Items]      
Amortization of deferred revenue (10,585) (9,317) (8,506)
Cash Received      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance 39,922 45,850  
Revenues earned under ESA [1] 11,274 11,048 11,330
Receipt of excess cash distributions 29,251 22,716 29,468
Receipt under tax receivable agreement 4,514 6,158 5,052
Ending Balance $ 45,039 39,922 45,850
Other Comprehensive Loss      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance   $ 2,735  
Ending Balance     2,735
Other Comprehensive Loss | NCM      
Schedule Of Equity Method Investments [Line Items]      
Equity in other comprehensive loss     $ 2,735
[1] Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $9,819, $10,523 and $11,110 for the years ended December 31, 2015, 2016 and 2017, respectively.